Doctolib: Business Overview, Financials & Competitive Analysis
Doctolib scores 8/10 on the AskCyborg Cyborg Score (Strong). Dominant European healthcare SaaS platform with strong unit economics and clear IPO pathway (expected late 2026/early 2027) targeting €6–8B valuation. In fiscal year 2024, the company reported an Annual Recurring Revenue (ARR) of €348 Million, representing a 22.5% increase from the previous year. The company operates a highly sticky B2B SaaS.
What is Doctolib's industry? Doctolib (doctolib.com) operates in Healthcare IT Services. AskCyborg classifies Doctolib under Healthcare IT Services in its company registry.
Doctolib is the dominant digital health infrastructure provider across France, Germany and Italy. The company's business model revolves around subscription fees paid by healthcare providers for using its software solu...
Cyborg Score thesis
Dominant European healthcare SaaS platform with strong unit economics and clear IPO pathway (expected late 2026/early 2027)...
Read the full analyst-debate transcript →Get the Latest Doctolib Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeDoctolib Overview
Pro stress-test →Doctolib is the dominant digital health infrastructure provider across France, Germany and Italy. The company's business model revolves around subscription fees paid by healthcare providers for using its software solutions, which include online appointment booking, teleconsultation services, and practice management tools. Founded in 2013, Doctolib has evolved from a simple booking platform into a comprehensive healthcare operating system serving millions of patients and healthcare professionals.
Strategic Profile
Pro stress-test →The company's trajectory is defined by the deep integration of agentic artificial intelligence, the pursuit of a multi-billion dollar public listing and the aggressive expansion into complex clinical and hospital ecosystems. Since late 2024 Doctolib has rolled out generative-AI features to cut documentation time; management targets reducing the 10-12 weekly hours doctors spend on paperwork. In May 2026, Doctolib acquired UK electronic patient record supplier Medicus, with the aim of bringing improved technology, AI and services to GP practices across the UK.
Competitive Landscape
Pro stress-test →Doctolib's top competitors include DocPlanner, MioDottore and Avimedical. Competitors such as Zocdoc, Practo, and Solv are vying to digitize patient access and clinical workflows. Doctolib maintains clear regional dominance in Continental Europe (France, Germany, Italy) with the most comprehensive platform integrating scheduling, telehealth, and practice management—a breadth few competitors match.
Industry Context
Doctolib operates in Healthcare IT Services.
Key facts
Founded: 2013 · Headquarters: Paris, France · Employees: 2,800–3,584 · Revenue: $402.6M ARR (FY2024)